Proton Pump Inhibitor Use and Bone Health in Patients With Rheumatic Diseases: A Cross-Sectional Study-Reference-Cited by-同舟云学术

Proton Pump Inhibitor Use and Bone Health in Patients With Rheumatic Diseases: A Cross-Sectional Study

Published:2024-07 Issue:7 Volume:99 Page:1046-1057
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Palmowski Andriko^ORCID,Schmajuk Gabriela,Yazdany Jinoos,Katz Patricia,Li Jing,Stovall Rachael,Kersey Emma,Nielsen Sabrina M.,Christensen Robin,Bliddal Henning,Boyadzhieva Zhivana,Schneider Udo,Alexander Tobias,Muche Burkhard,Hermann Sandra,Wiebe Edgar,Buttgereit Frank

Publisher

Elsevier BV

Reference52 articles.

1. Comprehension of top 200 prescribed drugs in the US as a Resource for pharmacy teaching, training and practice;Fuentes;Pharmacy (Basel),2018

2. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease;Sheikh;Am J Gastroenterol,2014

3. Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis;Liu;Life Sci,2019

4. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies;Poly;Osteoporos Int,2019

5. Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis;Nassar;J Bone Metab,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Proton Pump Inhibitor–Acid Suppressive Treatment Can Cause Vitamin B12 Deficiency in Zollinger–Ellison Syndrome (ZES) Patients;International Journal of Molecular Sciences;2024-07-02

2. The Long and Winding Road to Improving Bone Mineral Density Testing and Reporting;Mayo Clinic Proceedings;2024-07

3. Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases;Nature Reviews Rheumatology;2024-06-03